Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases J. BayryM. ThirionM. D. Kazatchkine BASIC STUDIES Pages: s217 - s221
Intravenous immunoglobulins in neurological disorders: safety issues M. M. Eibl BASIC STUDIES Pages: s222 - s226
Treatment of multiple sclerosis with intravenous immunoglobulin: review of clinical trials P. S. Sørensen MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s227 - s230
Antibodies and myelination: facts and misacts S. PluchinoL. ZanottiG. Martino MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s231 - s233
Immunoglobulin treatment of multiple sclerosis: future prospects L. DurelliA. RicciE. Verdun MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s234 - s238
Infantile encephalopathies G. B. Cavazzuti MULTIPLE SCLEROSIS AND RARE PATHOLOGIES Pages: s244 - s245
Immunoglobulins in chronic inflammatory demyelinating polyneuropathy G. ComiA. QuattriniL. Roveri PERIPHERAL NEUROPATHIES Pages: s246 - s250
Treatment of multifocal motor neuropathy E. Nobile-OrazioF. TerenghiA. Bersano PERIPHERAL NEUROPATHIES Pages: s251 - s255
High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials M. C. Dalakas MUSCULAR DISORDERS Pages: s256 - s259
